Swedish physicians' inclination to prescribe benzodiazepines: Differences between regions and characteristics of the prescriber

Scandinavian Journal of Public Health

Volumn 27, Issue 1, 1999, Pages 22-29

  Järbrink, Krister ^a   Carlsten, Anders ^b   Otto Frederiksen, Svend ^c  

^a National Board of Health and Welfare   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

attitudes; benzodiazepines; guidelines; medical speciality; prescription; private sector; public sector; region

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; FLUNITRAZEPAM; LORAZEPAM; NITRAZEPAM; OXAZEPAM;

ARTICLE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRIVATE PRACTICE; PROFESSIONAL PRACTICE LOCATION; PSYCHIATRY; SEX FACTORS; SPECIALTIES, MEDICAL; SWEDEN;

EID: 0033306476     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/14034948990270011201     Document Type: Article

References (25)

1. Nordenstam I., Wennberg M., Kristoferson K. Drug sales in Sweden 1997 (Svensk Läkemedelsstatistik 1997). Stockholm: Apoteksbolaget, 1998.
2. Wessling A., Bergman U., Westerholm B. On the differences in psychotropic drug use between the three major urban areas in Sweden. Eur J Clin Pharmacol 1991; 40: 495-500.
3. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 1998; 279: 526-31.
4. Carlsten A., Allebeck P., Brandt L. Are suicide rates in Sweden associated with changes in the prescribing of medicines? Acta Psychiatr Scand 1996; 94: 94-100.
5. Melander A., Henricson K., Stenberg P., et al. Anxiolytichypnotic drugs: relationships between prescribing, abuse and suicide. Eur J Phamacol 1991; 41: 525-9.
6. Isacson D., Carsjö K., Bergman U. Long-term use of benzodiazepines in a Swedish community: an eight-year follow-up. J Clin Epidemiol 1992; 45: 429-436.
7. Grimshaw J., Freemantle N., Wallace S., et al. Developing and implementing clinical practical guidelines. Qual Health Care 1995; 4: 55-64.
8. Grol R. Development of guidelines for general practice care. Br J Gen Pract 1993; 43: 146-151.
9. Haines A., Jones R. Implementing findings of research. BMJ 1994; 308: 1488-1492.
10. Björndal A., Fugelli P. Can regional differences in consumption of tranquillizers and hypnotics be explained by variations in general practitioners' threshold of prescribing? A methological study. Scand J Prim Health Care 1989; 7: 67-71.
11. Ekedahl A., Lidbeck J., Lithman T., Noreen D., Melander A. Benzodiazepine prescribing patterns in a high-prescibing Scandinavian community. Eur J Clin Pharmacol 1993; 44: 141-146.
12. King DJ, Griffiths K., Reilly PM, Merrett JD Psychotropic drug use in Northern Ireland 1966 - 80: prescribing trends, inter- and intra-regional comparisons and relationship to demographic and socioeconomic variables. Psychol Med 1982; 12: 819-833.
13. Kristensen P., Fjermestad T. Benzodiazepines - attitudes and prescription habits among general practitioners and psychiatrists. Tidsskr Nor Laegeforen 1991; 111: 2241-2245.
14. Holm M. General practitoners' training in psychiatry and prescription of psychotropic drugs. 2. Attitudes of physicians with training in psychotherapy and the extent of their prescriptions. Ugeskr Laeger 1990; 152: 2288-2290.
15. Heiman EM, Wood G. Patient characteristics and clinician attitudes influencing the prescribing of bensodiazepines. J Clin Psychiatry 1981; 42: 71-73.
16. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989.
17. SPSS Inc. SPSS for Windows version 6.0. Statistical Package for the Social Sciences. Chicago: SPSS Inc, 1993.
18. Morabia A., Fabre J., Dunand J-P. The influence of patient and physicians gender on prescription of psychotropic drugs. J Clin Epidemiol 1992; 45: 111-6.
19. Gulbrandsen P., Fugelli P., Sandvik L., Hjortdahl P. Influence of social problems on management in general practice: multipractice questionnaire survey. BMJ 1998; 317: 28-32.
20. Kirwan JR, de Caput Saintonge MD, Joyce CRB. Clinical judgement analysis. Quarterly Journal of Medicine, New Series 76, No 281. 1990: 935-49.
21. Hamilton IJD, Reay IM, Sullivan FM. A survey of general practitioners' attitudes to benzodiazepine overprescribing. Health Bulletin 48/6 November 1990: 299-303.
22. Ray WA, Blazer DG, Schaffner W., Federspiel CF, Fink R. Reducing long-term diazepam prescribing in office practice. A controlled trial of educational visits. JAMA 1986; 286: 2536-2539.
23. Ekedahl A., Andersson S., Hovelius B. Mölstad S, Liedholm H, Melander A. Drug prescription attitudes and behaviour of general practitioners. Effect of a problem-oriented educational programme. Eur J Clin Pharmacol 1995; 47: 381-7.
24. Denig P. Drug choice in medical practice rationales, routines and remedies. Dissertation. Groningen: Rijksuniversiteit Groningen, 1994.
25. Deans HG, Skinner P. Doctors' views on anxiety management in general practice. J R Soc Med 1992; 85: 83 - 86.